AS(強直性脊椎炎)に対してTNF阻害薬4剤 (レミケード, エンブレル, ヒュミラ, シンポニー)がいずれも有効と結論づけられたCochrane review (2015). ※TNF阻害薬間で効果, 副作用ともに優劣なし https://t.co/JZzW3f1mpG
@lucy_prodgers I hope it does, good chance it'll help with both... https://t.co/NDdvcZl0sH. They are right, my cursory reading is jury is out on Ustekinumab for AS. Has the GI team thought about tofacitinib? Might also help with AS (very new) https://t.co/
TNF-alpha inhibitors for ankylosing spondylitis - Maxwell - 2015 - Cochrane Database of Systematic Reviews - https://t.co/zSqmm5Mgyb
RT @NNTonthefly: New NNT→TNF-alpha inhibitors for ankylosing spondylitis. https://t.co/wmoRMjaL5Z
New NNT→TNF-alpha inhibitors for ankylosing spondylitis. https://t.co/wmoRMjaL5Z
moderate to high quality evidence that anti-TNF agents improve clinical symptoms of ankylosing spondylitis http://t.co/Mhoch2Qhf4